about
Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytesCurrent status of human papillomavirus vaccinesSafety assessment of adjuvanted vaccines: Methodological considerationsVaccines against bovine babesiosis: where we are now and possible roads aheadBringing influenza vaccines into the 21st century.Nanoparticle approaches against bacterial infectionsPoly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.The path of malaria vaccine development: challenges and perspectives.Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach.Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell ResponsesDiatoms and diatomaceous earth as novel poultry vaccine adjuvants.The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo.TLR Agonists as Adjuvants for Cancer Vaccines.The influence of adjuvant on UreB protection against Helicobacter pylori through the diversity of CD4+ T-cell epitope repertoire.Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.Vaccine adjuvants.Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice.Immunotherapy of hepatocellular carcinoma
P2860
Q26852816-843A537D-15C9-4503-8157-C355E54A6CD4Q26991640-EE763051-874C-4441-908B-F6DD83EA71A7Q27013956-45633394-0FD6-43F6-9592-A3B31F255D59Q29032177-3499C0C6-2A55-434F-8E4A-86E178D75C60Q30357413-5781A167-F2D9-41F8-8BD7-F780FB328FF1Q34339159-4F8701FD-D156-4612-B618-CC5C0E6CC668Q34455041-32D8D512-8153-4099-8929-A859F8B6A246Q38196455-6BBE0D90-D577-4A28-BC03-1F0976F5C4E1Q38364597-5F69133C-4C7A-40D5-8B37-B8A9F3EA2088Q38582086-C57F0697-3007-4A4C-BA0B-3A821AB08E35Q40644104-78225F8C-E435-487E-BB75-EBC3208B34C7Q41233846-4CD2CEB3-91FA-4ACB-B9DE-E3BCF1E55037Q41997055-825F4219-1D12-45D9-A4FC-BD0D9F981F41Q42366604-0CB785E6-AC5A-4F79-988B-83872E3C120EQ42378276-5C1F04B4-C44D-4347-BA42-BFDB3276EAF5Q44800976-CFCA0174-8572-48CF-9873-82E72D340655Q49937419-3F73B7B6-8F42-43E9-84E1-5167CCDA83A4Q56896669-61453245-7DD3-4400-8A98-BEC5C6550DA7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Combination of adjuvants: the future of vaccine design.
@en
type
label
Combination of adjuvants: the future of vaccine design.
@en
prefLabel
Combination of adjuvants: the future of vaccine design.
@en
P2093
P2860
P1476
Combination of adjuvants: the future of vaccine design.
@en
P2093
Adele Mount
Adriana Baz Morelli
Anabel Silva
Debbie Drane
Eugene Maraskovsky
Sandra Koernig
P2860
P304
P356
10.1586/14760584.2013.811185
P577
2013-07-01T00:00:00Z